Articles by Cynthia Challener, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Cynthia Challener, PhD

GlaxoSmithKline Adopts Continuous Manufacturing for Preparation of Key Intermediate

Use of a continuous-flow reaction made it possible to scale up a highly exothermic reaction for the production of a key Suzuki−Miyaura coupling reagent.
Oct 9, 2013

Use of a continuous-flow reaction made it possible to scale up a highly exothermic reaction for the production of a key Suzuki−Miyaura coupling reagent.

GlaxoSmithKline, Novartis, and AstraZeneca Fund Center Focused on Advancing Commercial-Scale Continuous Crystallization

Through partnerships and collaborations between academia, industry, and the public sector, the Center for Continuous Manufacturing and Crystallization is advancing continuous crystallization technologies.
Oct 9, 2013

Through partnerships and collaborations between academia, industry, and the public sector, the Center for Continuous Manufacturing and Crystallization is advancing continuous crystallization technologies.

GlaxoSmithKline Adopts Continuous Manufacturing for Preparation of Key Intermediate

Use of a continuous-flow reaction made it possible to scale up a highly exothermic reaction for the production of a key Suzuki−Miyaura coupling reagent.
Sep 25, 2013

Use of a continuous-flow reaction made it possible to scale up a highly exothermic reaction for the production of a key Suzuki−Miyaura coupling reagent.

Pfizer Applies Integrated Technology for Cell-Line Development of Proprietary Antibodies

Pfizer advances its pipeline of antibody-based therapies using a host cell line that combines engineered glycosylation technology and enhanced gene-expression.
Sep 25, 2013

Pfizer advances its pipeline of antibody-based therapies using a host cell line that combines engineered glycosylation technology and enhanced gene-expression.

Exploring Single-Use Systems for Fill-Finish Operations

The need to develop a final formulation process for a parenteral product sensitive to stainless-steel gave Patheon the opportunity to evaluate the potential of single-use technology in fill-finish operations.
Sep 25, 2013

The need to develop a final formulation process for a parenteral product sensitive to stainless-steel gave Patheon the opportunity to evaluate the potential of single-use technology in fill- finish operations.

Granulation Method and Process Monitoring Matter

The characteristics of tableted solid dosage drugs often depend on the granulation process, so selecting the most appropriate granulation technique and monitoring the process are crucial
Sep 25, 2013

The characteristics of tableted solid dosage drugs often depend on the granulation process, so selecting the most appropriate granulation technique and monitoring the process are crucial

Laser Headspace Analysis Advantageous for Monitoring Sterile Fill-Finish Operations

Measuring headspace gas composition and pressure allows sterile product manufacturers to simultaneously monitor important quality parameters rapidly and nondestructively.
Sep 25, 2013

Measuring headspace gas composition and pressure allows sterile product manufacturers to simultaneously monitor important quality parameters rapidly and nondestructively.

Sigma-Aldrich, The Scripps Research Institute Translating Research into Commercial Applications

New partnership aims to eliminate months from the typical transition time required to move chemistry from the laboratory into commercial applications.
Sep 11, 2013

New partnership aims to eliminate months from the typical transition time required to move chemistry from the laboratory into commercial applications.

Avoiding Glass Delamination with Early Product/Container Testing

Determining the potential for glass delamination before a product goes to market is the best way to ensure product safety and prevent expensive recalls.
Sep 11, 2013

Determining the potential for glass delamination before a product goes to market is the best way to ensure product safety and prevent expensive recalls.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here